Introduction
============

Embryonic stem cells (ESCs) are available sources for clinical therapies because of their unlimited self-renewal ability and potential to generate differentiated cell types (pluripotency) ([@R1]). Self-renewal and pluripotency properties are regulated by an array of protein--coding genes such as those encoding transcription factors and chromatin remodeling enzymes ([@R2]). OCT4, a transcription factor belonging to the family of POU transcription factors lies at the center of this circuitry and controls a wide range of downstream genes ([@R3]).

Extensive studies have indicated that OCT4 with other pluripotency factors are required for self-renewal and pluripotency of embryonic stem cells and embryonic carcinoma cells (ECC) ([@R4]-[@R6]). In developing mouse embryo, OCT4 is expressed in early cleavage stage, inner cell mass, primitive ectoderm and primordial germ cells and downregulated in the trophectoderm ([@R7]). The suppression of OCT4 expression in developing embryo or in cultured human or mouse ES and EC cells leads to the loss of pluripotency and subsequently differentiation into trophectoderm ([@R7], [@R8]), whereas transgene-mediated overexpression of OCT4 triggers differentiation of embryonic cells into endodermal or mesodermal structures ([@R4], [@R9]). In addition to embryonic cells, germ cells and germ cell tumors, OCT4 expression has been reported in several adult somatic cells ([@R10]) and in various cancer cell lines and primary tumors ([@R11], [@R12]). OCT4 expression in somatic cells has been suggested to be restricted to small populations of multipotent cells with high self-renewal capacity, namely the adult stem cells in normal tissues and cancer stem cells in tumor samples ([@R10], [@R13], [@R14]). Recently, OCT4 expression has also been reported in terminally differentiated peripheral blood mononuclear cells (pBMSC) ([@R15]).

Although many features of an mRNA can contribute to its translation, most control elements are located within untranslated regions (UTRs)([@R16]). Three-prime untranslated region (3´ UTR) is a particular section of mRNA that follows the coding region and is not translated to protein. 3´UTR has several regulatory roles. In 3´ UTR, there exist regulatory sequences such as polyA adenylation signals, binding sites for miRNAs that may cause the suppression of mRNA expression and binding sites for proteins that may affect the mRNA stability or location in the cell. Genetic alterations in 3\' UTR can be used to increase or decrease the half-life of mRNA, leading to higher or lower protein levels ([@R17]-[@R20]). Overall translation rates are also affected by characteristics of 5´ UTR, including length and start site consensus sequences as well as the presence of secondary structures, upstream AUGs, upstream open reading frames (uORFs) and internal ribosome entry sites (IRES). Also, 5´ UTRs can contain sequences functioning as binding sites for regulatory proteins. These regulatory proteins may affect the mRNA stability or translation. For instance, iron responsive elements are able to regulate gene expression in response to iron ([@R19], [@R21], [@R22]).

Alterations in UTR cis-regulatory sequences could affect the expression of specific genes at the level of translation. Such modifications may turn the physiological balance from healthy to diseased state, evoking a variety of conditions such as cancer. This information tends to establish the prominent role of UTRs, perhaps as much as those of coding sequences, in health and disease ([@R23]). Findings accumulated over the substantial role of UTRs in gene regulation render the investigation of these regulatory sequences imperative. This could be overwhelmingly notable in pluripotent cells offering insights to unravel the mechanisms underlying pluripotency state.

In this work, we aimed to investigate the potential regulatory role of the *Oct4* 5´UTR and 3´UTR in gene expression. To this end, we cloned the *Oct4* 5´ UTR and 3´ UTR regions singly and in combination into pGL3 vector upstream and downstream of luciferase (as reporter gene), respectively. Subsequently, the vectors were transfected into BMSC and p19 cells and luciferase expression was evaluated.

Materials and Methods
=====================

Cloning of the *Oct4* 5´UTR and 3´UTR sequences in pGL3 vector
--------------------------------------------------------------

To amplify the 3´UTR sequence of murine *Oct4*, total RNA was extracted from CCE cell line using RNA extraction kit (Exiqon, Denmark). The extracted RNA was treated with TURBO DNAase (Ambion, Austin, TX) to remove DNA contamination, and then investigated qualitatively by electrophoresis on 1% agarose gel and quantitatively by measuring the absorbance at 260 nm. Subsequently, the amplification of 3´UTR - the fragment spanning from nucleotide 1076 to 1346 (Gene ID: 18999 pou5f1) - was conducted through RT-PCR reaction. The sequences of the primers used for RT-PCR were as follows:

*Forward primer*

5´TTTT[TCTAGA]{.ul}TCTGTTCCCGTCACTGCTC 3´

*Reverse primer*

5´TTT[TCTA**GA**]{.ul}**ATT**CAGCTATCTACTGTGTGTCCC 3´

The XbaI site was introduced into forward primer and overlapping XbaI and EcoRI sites were introduced into reverse primer. The XbaI sites are underlined and EcoRI site is boldfaced. The incorporation of restriction sites was performed for convenience of cloning procedure.

To clone the *Oct4* 3´UTR in pGL3 vector, the amplified 3´UTR fragment was digested with XbaI, electrophoresed on 1% agarose gel and purified from agarose gel by gel purification kit (Bioneer, South Korea). Also, pGL3 vector was digested with XbaI. The *Oct4* 3´UTR was inserted into the XbaI site of pGL3 vector, downstream of the LUC gene.

The second PCR reaction was performed for two purposes: to determine the orientation of 3´UTR cloned in the previous step and to amplify the *Oct4* 5´UTR. PCR was carried out using pFU DNA polymerase and the following forward and reverse primers on pGL3-3´UTR vector as template. It is to be mentioned that the reverse primer was the same used for amplifying the *Oct4* 3´UTR:

*Forward primer*

5´ TTTT[AAGCTT]{.ul}AACCGTCCCTAGGTGAGCCGTCTTTCCACCAG 3´

*Reverse primer*

5´ TTT[TCTA**GA**]{.ul}**ATT**CAGCTATCTACTGTGTGTCCC 3´

32 nucleotides of the *Oct4* 5´UTR were synthesized as part of forward primer. Also, AAGCTT - target site for Hind III enzyme -- was introduced into forward primer. The amplified fragment contained *Oct4* 5´UTR, LUC gene and 3´UTR. To construct pGL3-5´&3´UTRs vector, this fragment was inserted into pGL3 vector digested with HindIII and XbaI. To obtain pGL3-5´UTR vector, pGL3-5´&3´UTR was digested with XbaI, electrophoresed on 1% agarose gel, and purified from agarose gel by gel purification kit (Bioneer Company, South Korea). The digested plasmid was then self-ligated using T4 DNA ligase. Cloning experiments were confirmed by restriction enzyme analysis and sequencing. Figure [1](#F1){ref-type="fig"} indicates the schematic picture of pGL3 vector with cloned 5´UTR and 3´UTR sequences.

Cell culture and vector transfection
------------------------------------

Bone marrow stem cells (BMSC) were isolated from mouse femur and tibia by flushing the bone shafts with special buffer (phosphate-buffered saline supplemented with 0.5 % bovine serum albumin, pH=7.2) as described previously ([@R24]). Mouse BMSCs were maintained in α-MEM medium (Gibco, USA) supplemented with 20% FBS in a 5% CO~2~ incubator. P19, mouse embryonic carcinoma cell line, is a teratocarcinoma cell line derived from transplant epiblast mouse embryonic cells. P19 cells were grown in α-MEM medium (Gibco, USA) supplemented with 10% FBS, 100 unit/ml of penicillin, and 100 µg/ml of streptomycin. Cells were plated 24 hr before transfection in 24-well plates and transfected with lipofectamin 2000 (Invitrogen, USA) following the manufacturer's protocol. After 48 hr, cells were harvested and lysed in 1X passive lysis buffer.

Luciferase assay
----------------

48 hrs after transfection, cells were washed with PBS twice and lysis buffer was added to each well. After 15 min of incubation at 4°C temperature, the cells were harvested and transferred to tubes. Following vortexing for 15 sec, luciferase activity was measured in terms of relative light unit (RLU). The activity of luciferase was measured using Sirius tube luminometer (Berthold detection system). Each transfection experiment was performed in duplicate and repeated at least twice.

Statistical analysis
--------------------

All experiments were replicated three times. The results of luciferase expression were analyzed by ANOVA and t-test in order to determine the difference of luciferase count (indicated as RLU) among different vectors transfected into cells (SPSS 13 software and GraphPad Prism 6). Statistical significance was considered as *P*\<0.05.

Results
=======

Construction of UTR-containing vectors
--------------------------------------

Construction of three vectors pGL3- 5´UTR, pGL3- 5´& 3´UTRs and pGL3-3´UTR was conducted to analyze the regulatory roles of UTR sequences of mouse *Oct4* gene. The amplified *Oct4* 3´UTR was cloned into XbaI site downstream of LUC gene in pGL3 vector (Figure [2A](#F2){ref-type="fig"} and [2B](#F2){ref-type="fig"}) to generate pGL3-3´UTR. 5´UTR-LUC-3´UTR fragment - amplified from pGL3-3´UTR by using forward primer containing 32 nucleotides of 5´UTR as an overhang tail and reverse primer complementary to a part of 3´ UTR - was used for ligation into pGL3 vector. Both PCR product and vector were digested with XbaI and Hind III enzymes. This resulted in construction of the vector pGL3-5´& 3´UTRs (Figure [2C](#F2){ref-type="fig"}). For generation of pGL3 harboring solely *Oct4* 5´UTR, pGL3- 5´& 3´UTRs vector was digested with XbaI and then self-ligated which led to the production of pGL3-5´UTRvector (Figure [2D](#F2){ref-type="fig"}). The cloning of UTR sequences and construction of plasmids were confirmed by restriction enzyme analysis and sequencing.

Cell transfection and luciferase assay
--------------------------------------

Transfection of cells with constructed vectors was used to evaluate the effects of *Oct4* 5´UTR and 3´UTR on gene regulation. Luciferase expression (in terms of relative light unit; RLU) was compared among pGL3-5´UTR, pGL3-5´& 3´UTRs and pGL3-3´ UTR vectors with pGL3 as control which was lacking any UTR sequences. This property leads to the resistance of control vector to regulation factors (such as microRNAs) interacting with UTR.

Evaluation of reporter gene expression was conducted 48 hr post-transfection. One-way ANOVA test indicated a significant decrease (*P*\<0.05) in luciferase expression in BMSC cells following transfection with pGL3-5´UTR, pGL3-5´& 3´UTRs and pGL3-3´ UTR (Figure [3A](#F3){ref-type="fig"}). This analysis also exhibited that transfection of P19 cells with pGL3-3´UTR leads to a significant reduction (*P*\<0.05) in luciferase expression. However, transfection with pGL3-5´ UTR and pGL3-5´& 3´UTRs resulted in the enhancement of luciferase expression (Figure [3B](#F3){ref-type="fig"}).

Discussion
==========

OCT4, as a POU transcription factor, resides at the top of a transcriptional hierarchy that is responsible for the initiation and/or maintenance of the expression of a group of genes positively regulating the pluripotent phenotype and repressing those genes associated with differentiation ([@R25]). Thus conferring a prominent position in the ranking of transcriptional regulators of mammalian cell fate to OCT4 ([@R7]). Expression of OCT4 is regulated at the transcriptional level by cis-acting elements located upstream of the *Oct4* gene and methylation of chromatin structure. Although transcriptional networks controlled by OCT4 have been delineated and several proteins that interact with OCT4 have been identified, the mechanisms through which OCT4 is post-transcriptionally regulated have largely remained unexplored ([@R2], [@R26]) and this area has continued to be a conspicuous black box in our understanding of the circuitry which controls pluripotency. Therefore, comprehending the post-transcriptional regulatory mechanisms of OCT4 in stem and cancerous cells which assists in understanding the molecular basis of the pluripotent phenotype is fundamental to realizing their therapeutic potential and unraveling the molecular and cellular mechanisms of pluripotency. This information ultimately leads to novel treatments for certain malignancies.

In this study, we investigated the effects of mouse *Oct4* UTRs as post-transcriptional modulators on the expression of luciferase reporter gene in mouse P19 embryonal carcinoma (EC) cells and BMSCs. Transfection experiments conducted by pGL3-5´UTR, pGL3-5´&3´UTRs and pGL3- 3´UTR demonstrated that in BMSC cells all three vectors provoke the reduction of luciferase expression, whereas in p19 cells transfection with pGL3-3´UTR leads to the decline of luciferase expression and transfection with pGL3-5´UTR and pGL3-5´&3´UTRs elicits the augmentation of reporter gene expression.

The main reasons for the variation of effects of *Oct4* UTR sequences on luciferase gene expression observed in our study could be explained in view of the cell context in which these UTRs act as well as the dissimilarities of 5´ UTR and 3´ UTR sequences. The combination of these parameters could determine the ultimate function of these UTRs thereby specifying whether these regulatory regions have negative or positive role in the regulation of gene expression. Overwhelming evidence supports the fundamental concept that no common regulatory network exists among various cell lineages ([@R27]). Therefore, elements within the same mRNA are likely to undergo differential regulation dependent upon disparate spatial and/or temporal contexts ([@R16]) such as various cell types utilized in our study. It has been suggested that, in spite of continuous expression of OCT4 in a variety of pluripotent cell lineages from ICM through the primitive ectoderm to PGC, its expression level is controlled by distinct mechanisms depending on the developmental stage or cell type. For instance, the OCT4 expression in ICM and PGC - ES cells is specifically activated by the distal enhancer (DE), whereas its expression in the primitive ectoderm or P19 EC cells is regulated by the proximal enhancer (PE) ([@R28]). This discrepancy in the control of gene expression also holds true at the post-transcriptional level and different results obtained from BMSCs and P19 cells is due to the fact that the environment of P19 embryonal carcinoma cell line is principally of a different kind in comparison with BMSCs. This leads to the diverse mechanisms of post-transcriptional regulation of OCT4 functioning in these different cellular contexts.

The expression of OCT4 has been reported in embryonic stem cells ([@R29]) and adult somatic tissues. Bone marrow cells of both human and mouse, particularly hematopoietic and mesenchymal stem cells (HSCs and MSCs), have been the most frequently cited source of OCT4 expression in somatic tissues. Hence, it could be inferred that OCT4 may not only be crucial for the maintenance of pluripotency in embryonic cells but may also play an important role in the self-renewal of somatic stem cells and in maintaining tissue homeostasis ([@R30], [@R31]).

Murine P19 embryonal carcinoma cells exhibit greater amount of *Oct4* expression relative to BMSCs (somatic stem cells). This discrepancy in the expression level of *Oct4* is closely correlated with difference in self-renewal and pluripotency capacity of these cells which conforms to their markedly distinguishable characteristics as embryonic and somatic stem cells. We could hypothesize that in BMSCs there exist negative regulatory elements including microRNAs required to keep the expression of *Oct4* in lower levels compared to P19 cells. These microRNAs are able to bind to the *Oct4* UTR and impede the expression of luciferase reporter gene.

Different behaviors of *Oct4* UTRs in P19 and BMSCs could also be attributed to the dissimilarity between 5´UTR and 3´UTR in some evolutionarily crucial aspects. Studies based upon quantitative analysis of UTR length have yielded some insight into the roles played by 5´UTR and 3´UTR in the control of gene expression. A computational multispecies analysis of a large UTR database suggests that the mean 3´UTR length in human transcripts is several times longer than the mean human 5´UTR length ([@R32]). It has also become evident that 5´UTR average length is constant, roughly 200 nucleotides, while more striking differences are observed for mRNAs 3\'UTRs in which the length of mRNA 3´UTR is significantly greater in vertebrates than invertebrates, plants and fungi ([@R33]). In addition, the average length of 3´UTR sequences has increased during evolution, suggesting their possible contribution to organism complexity. By contrast, the 5´UTR length is remarkably consistent in organisms ranging from fungi and plants to invertebrates and vertebrates, including human. This evolutionary expansion of the 3´UTR reveals that there is substantial potential for 3´UTR-based translational regulation during evolution ([@R34]), and that such control mechanisms might be significant in determining differences among various cell types. The greater length of 3´UTR sequences in mRNAs might be connected to the fact that they have acquired new functions in evolution ([@R33]). Taken together, the more extended length of 3´UTRs during evolution among organisms and relative to 5´UTR in the same organism is indicative of their greater functional conservation in gene regulation which could explain the functional constancy of the *Oct4* 3´UTR in two different cellular contexts.

Taking into account recent reports which show differentiation of somatic stem cells ([@R35]) and the fact that mouse ESCs ([@R36], [@R37]) can be modulated by miRNAs through post-transcriptional attenuation of key pluripotent factors, the identification of miRNA target sites on the UTRs of *Oct4* could be beneficial in detailing mechanisms underlying the function of these UTRs. Expression analyses and computational predictions have demonstrated miR-145 can target 3´UTRs of *Oct4*, Sox2, and *Klf4* in luciferase assays in both HeLa cells and hESCs ([@R14]). Other miRNAs may also be involved in the negative regulation of these 3´UTRs, considering the prediction of many miRNA target sites in human *Oct4*, *Sox2*, and *Klf4* 3´UTRs([@R1]). Targets of miRNA regulation are inherently difficult to identify due to the partial complementarity between the miRNAs and the target mRNA. For this reason, focus has largely been on computational prediction of targets ([@R38]). Thus, we conducted bioinformatic analysis to predict microRNAs associated with UTR regions of *Oct4* mRNA. To identify the miRNA targets on the *Oct4* 5´UTR and 3´UTR, we took advantage of miRWalk database ([@R39]). Based on the prediction, 29 miRNAs can recognize their targets by binding to motives in the 3´UTR sequence of *Oct4* and 5 miRNAs can recognize their targets by binding to motifs in the 5´UTR sequence of *Oct4* (data not shown). Comparing miRNA target sites on 5´UTR and 3´UTR, we observed the larger number of target sites on the *Oct4* 3´UTR indicating the remarkably greater significance of miRNA regulation on the 3´UTR of *Oct4* compared to the 5´UTR of *Oct4*. One of the microRNAs binding to the *Oct4* 5´UTR recognized through our analysis which was miR21 previously indicated to repress stem cell factors such as OCT4, NANOG, SOX2, and C-MYC ([@R23]). It is worthy of note that the number of microRNA target sites known through bioinformatic tools usually is lower than those identified by experimental approaches. The challenge of establishing miRNA functions and understanding the biological processes they regulate has emphasized the need for experimental approaches to identify miRNA targets ([@R38]). It is self- explanatory that the functional analysis of microRNAs underlying the regulation of *Oct4* UTRs will identify novel mechanisms that determine the maintenance of P19 and BMSC pluripotecy.

Conclusion
==========

Examination of OCT4 regulation with respect to its diverse biological functions is of great significance. This study sheds some light on the part played by the UTR regions of mouse *Oct4* in regulating gene expression in BMSCs and P19 cells and is only the starting point in appreciating the processes underlying post-transcriptional regulation of OCT4 in various pluripotent cells. This information may elucidate the mode of post-transcriptional regulation of OCT4 as one of the most potent factors mediating pluripotency. Certainly, more detailed work will be required to understand the key regulatory elements affecting the UTR regions of *Oct4* and also particularize the effects of these interacting factors on the activity of *Oct4* mRNA. This knowledge could aid us in conceiving the fact that how OCT4 exerts its pleiotropic affects in various cell lines as well as drawing general principles that define the commonalities and differences of OCT4 regulation among different stem cells. Being of special importance, microRNAs specifically associated with *Oct4* UTRs will be at the focus of our future study.
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![The schematic picture of pGL3 vector containing the *Oct4* 5´UTR and 3´UTR (developed by Plasmidomics 0.2 software)](IJBMS-17-490_F1){#F1}

![Schematic representation of the section of pGL3 vector used for cloning of 5´UTR and 3´UTR sequences: A) pGL3 vector without UTR sequences B) pGL3-3´UTR vector with pSV40-LUC- *Oct4* 3´UTR construct C) pGL3- 5´& 3´UTRs vector with pSV40- *Oct4* 5´UTR-LUC-*Oct4* 3´UTR construct D) pGL3- 5´UTR vector with pSV-*Oct4* 5´UTR-LUC](IJBMS-17-490_F2){#F2}

![Graphs indicating the effects of transfected vectors on luciferase expression. A) In upper graph, transfection of BMSCs with pGL3-3´UTR, pGL3- 5´& 3´ UTRs and pGL3- 5´UTR vectors resulted in a significant decrease of luciferace expression (*P*\<0.05). B) In lower graph, trasfection of P19 with pGL3 3´UTR vector led to a significant reduction (*P*\<0.05), while transfection with pGL3-5´&3´UTRs and pGL3-5´UTR induced an increase of luciferase expression. The vertical axis shows luciferase expression in terms of RLU (relative light unit)](IJBMS-17-490_F3){#F3}
